Idorsia (LTS:0RQE) Days Payable : 1,361.09 (As of Sep. 2023)

View and export this data going back to 2017. Start your Free Trial

What is Idorsia Days Payable?

Idorsia's average Accounts Payable for the three months ended in Sep. 2023 was CHF21.6 Mil. Idorsia's Cost of Goods Sold for the three months ended in Sep. 2023 was CHF1.4 Mil. Hence, Idorsia's Days Payable for the three months ended in Sep. 2023 was 1,361.09.

The historical rank and industry rank for Idorsia's Days Payable or its related term are showing as below:

LTS:0RQE' s Days Payable Range Over the Past 10 Years
Min: 894.53 Med: 1523.11 Max: 1523.11
Current: 894.53

During the past 7 years, Idorsia's highest Days Payable was 1523.11. The lowest was 894.53. And the median was 1523.11.

LTS:0RQE's Days Payable is ranked better than
83.82% of 717 companies
in the Biotechnology industry
Industry Median: 147.46 vs LTS:0RQE: 894.53

Idorsia's Days Payable increased from Sep. 2022 (808.75) to Sep. 2023 (1,361.09). It may suggest that Idorsia delayed paying its suppliers.

Idorsia Days Payable Historical Data

The historical data trend for Idorsia's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Idorsia Days Payable Chart

Idorsia Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Days Payable

Get a 7-Day Free Trial

1,523.11

Idorsia Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Days Payable	Get a 7-Day Free Trial															808.75	749.03	2,810.35	542.88	1,361.09

Competitive Comparison of Idorsia's Days Payable

For the Biotechnology subindustry, Idorsia's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Idorsia's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Idorsia's Days Payable distribution charts can be found below:

* The bar in red indicates where Idorsia's Days Payable falls into.

Idorsia Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Idorsia's Days Payable for the fiscal year that ended in Dec. 2022 is calculated as

	Days Payable (A: Dec. 2022 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2021 )	+	Accounts Payable (A: Dec. 2022 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2022 )	*	Days in Period
=	( (26.86	+	25.435)	/	2 )	/	6.266	*	365
=	26.1475					/	6.266	*	365
=	1,523.11

Idorsia's Days Payable for the quarter that ended in Sep. 2023 is calculated as:

	Days Payable (Q: Sep. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Jun. 2023 )	+	Accounts Payable (Q: Sep. 2023 ))	/	count )	/	Cost of Goods Sold (Q: Sep. 2023 )	*	Days in Period
=	( (24.795	+	18.372)	/	2 )	/	1.447	*	365 / 4
=	21.5835					/	1.447	*	365 / 4
=	1,361.09

Idorsia Days Payable Related Terms

Thank you for viewing the detailed overview of Idorsia's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Idorsia (LTS:0RQE) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Idorsia Ltd (LTS:0RQE) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

IDRSF:USA IDIAz:UK IDIA:Switzerland

Address

Hegenheimermattweg 91, Allschwil, CHE, 4123

Website

https://www.idorsia.com

Idorsia Ltd is a biopharmaceutical company engaged in discovering, developing, and commercializing of medicines for unmet medical needs. It is a biotech hub of Europe specialized in the discovery and development of small molecules, to provide innovative therapeutic options. The company focuses on multiple therapeutic areas which include the central nervous system, cardiovascular disorders, immunological disorders, and orphan diseases. Idorsia's development compounds target a number of different diseases such as Resistant Hypertension, lupus, insomnia, Cerebral vasospasm, and Fabry disease. Geographically, it derives revenue from Switzerland.

Idorsia (LTS:0RQE) Headlines

No Headlines